Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 422 - 422
Published: Feb. 10, 2025
The
intricate
relationship
between
anticancer
drugs
and
the
gut
microbiome
influences
cancer
treatment
outcomes.
This
review
paper
focuses
on
role
of
integrity
in
enhancing
efficacy
safety
drug
therapy,
emphasizing
pharmacokinetic
interactions
microbiota.
It
explores
how
disruptions
to
composition,
or
dysbiosis,
can
alter
metabolism,
immune
responses,
side
effects.
By
examining
mechanisms
disruption
caused
by
drugs,
this
highlights
specific
case
studies
like
cyclophosphamide,
5-fluorouracil,
irinotecan,
their
impact
microbial
diversity
clinical
also
discusses
microbiome-targeted
strategies,
including
prebiotics,
probiotics,
postbiotics,
fecal
microbiota
transplantation
(FMT),
as
promising
interventions
enhance
treatment.
Furthermore,
potential
profiling
personalizing
therapy
integrating
these
into
practice
is
explored.
Finally,
proposes
future
research
directions,
developing
novel
biomarkers
a
deeper
comprehension
drug-microbiome
interactions,
respond
current
gaps
knowledge
improve
patient
outcomes
care.
Language: Английский
The Impact of Cell-Intrinsic STAT6 Protein on Donor T Cell-Mediated Graft-Versus-Tumor Effect
Xiaoqun Guan,
No information about this author
Hope Fury,
No information about this author
Priya D. Issuree
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 280 - 280
Published: Dec. 31, 2024
Bone
marrow
transplantation
(BMT)
is
mainly
performed
to
restore
an
anti-tumor
immune
response,
called
the
graft-versus-tumor
(GVT)
effect,
against
leukemia,
myeloma
and
lymphoma.
This
GVT
reactivity
driven
by
donor
T
cells,
it
can
also
cause
lethal
graft-versus-host
disease
(GVHD).
We
previously
demonstrated
that
colonization
of
mice
with
helminths
preserves
response
while
suppressing
GVHD.
As
helper-2
(Th2)
pathway
critical
helminthic
regulation,
we
asked
whether
genetic
induction
Th2
signaling
in
cells
regulation
after
BMT.
Our
studies
utilized
transgenic
lymphocytes
overexpress
a
constitutively
active
form
Th2-associated
transcription
factor
STAT6.
Constitutively
STAT6
sustained
without
causing
severe
acute
GVHD,
where
generated
robust
quantities
cytotoxic
proteins
important
such
as
granzymes
A
B,
interferon-γ
Fas
ligand,
addition
generating
high
Th2/regulatory
cytokines.
Bioinformatic
analysis
based
on
chromosome
precipitation
experiments
indicated
stimulates
expression
directly.
Thus,
preserving
GVHD
mortality,
our
results
indicate
therapeutic
potential
restoring
modulation
targeting
STAT6-dependent
cell
maturation.
Language: Английский